Webinar: Thursday, 28 November 2024, 7PM

HIV therapies: A survey of the cutting edge

Cutting-edge advancements in our understanding of HIV/Aids have lead to a tremendous transformation in the state of care. Long-acting injectable formulations, broadly neutralising antibodies PrEP and therapeutic vaccines point to a future where the virus could be eradicated or long-term remission could be achieved without the need for continuous medication. Join us for a webinar with HIV expert Prof Linda-Gail Bekker to examine the current and future state of HIV medicine. This webinar is accredited for 1 General CPD point and it is proudly sponsored by Adcock Ingram.

Presented by
Conrad Strydom

Conrad Strydom

  • Editor: Medical Academic
Prof Linda-Gail Bekker

Prof Linda-Gail Bekker

  • Deputy Director: Desmond Tutu HIV Centre
Prof Linda-Gail Bekker (MBChB, DTMH, DCH, FCP (SA), PhD) is the Director of the Desmond Tutu HIV Centre at the Institute of Infectious Disease and Molecular Medicine, UCT and Chief Executive Officer of the Desmond Tutu Health Foundation. She is a physician, scientist and infectious disease specialist. Her research interests include programmatic and action research around antiretroviral roll-out and TB integration, prevention of HIV in women, youth and MSM. Prof Bekker served as President-Elect (2014- 2016) and then President (2016-2018) of the International AIDS Society. She is an A+ rated scientist, and has published >600 peer-reviewed papers. 

1,293 professionals have already registered.

Days
:
Hours
:
Minutes
:
Seconds

Webinar Registration

By registering for this webinar, you agree to our Terms & Conditions.

New Media, a division of Media24 (PTY) Ltd., abides to all data and privacy requirements. To find out more about our Privacy Policy you can find it here: www.media24.com/group-privacy-portal.

Please Note: The names, surnames, email addresses and duration of attendance of all webinar participants will be shared for statistical purposes only, with the sponsor of this webinar. No delegate will be contacted by the sponsor with marketing or sales offers, and your information will not be shared with any third-parties.

Should you wish to receive further information on the webinar topic from our sponsor, please opt in above.